首页 | 本学科首页   官方微博 | 高级检索  
检索        

�ҹ�������ҩӦ����״������Բ߳�̽
引用本文:��ˬ,������,���,�罡��.�ҹ�������ҩӦ����״������Բ߳�̽[J].中国药学杂志,2016,51(8):678-682.
作者姓名:��ˬ  ������  ���  �罡��
作者单位:1.???????????????,???? 100035;
2.????????????1???????????,???? 100191
摘    要:

关 键 词:???????  ???????  ??????  ??????  ?????  

The Application Status of Adjuvant Drugs in Our Country and the Management Countermeasures Study
HAN Shuang,ZHONG Min-tao,LI Jin,ZHEN Jian-cun.The Application Status of Adjuvant Drugs in Our Country and the Management Countermeasures Study[J].Chinese Pharmaceutical Journal,2016,51(8):678-682.
Authors:HAN Shuang  ZHONG Min-tao  LI Jin  ZHEN Jian-cun
Institution:1.Department of Pharmacy, Beijng Jishuitan Hospital, Beijing 100035, China;
2.Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Science, Peking University, Beijing 100191, China
Abstract:??OBJECTIVE To know the current application status of the adjuvant drugs in our country, and preliminary explore the management measures of adjuvant drugs. METHODS Through searching, reading, and summarizing the relevant content and literature, the application status of adjuvant drugs in China and the global demand for rationalization of drug use were reviewed. A few questionnaires that associated with adjuvant drugs were designed by Delphi method to investigate the medicine experts nationwide and to explore the management countermeasures of adjuvant drugs. RESULTS The survey showed that 98% of medical institutions existing adjuvant drugs use of unreasonable/no specification. The medicine experts believe that there are unreasonable usages such as traditional Chinese medicine injections, cancer drugs except for chemotherapy drugs, etc. The unified management of adjuvant drugs application should determined by the state. CONCLUSION The excessive use of adjuvant drugs ubiquitous in our country. Key monitoring varieties directory of adjuvant drugs and the limit to the drugs?? use indicators to evaluate the rationality of drug use should be set. And there can be a special review team to review the use of adjuvant at regular intervals in order to standardize the clinical application of adjuvant drugs.
Keywords:
点击此处可从《中国药学杂志》浏览原始摘要信息
点击此处可从《中国药学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号